DRC Ebola Outbreak 2026: The Bundibugyo Crisis No One Had a Vaccine For

Government Strategy Overhaul

On August 6, 2026, Bloomberg reported that the DRC government is preparing a sweeping overhaul of its response. The plan includes providing free healthcare in Ebola-affected eastern provinces, scaling up testing of experimental vaccines, and shifting to a village-led response model to contain the spread as new cases continue to spike .

The Bundibugyo Strain Challenge

Unlike the more common Zaire ebolavirus, no approved vaccines or specific treatments exist for the Bundibugyo strain . This forces responders to rely on supportive care, early detection, and strict infection control — tools that are far harder to deploy effectively in active conflict zones . The WHO notes that no licensed vaccine or specific treatment is available for Bundibugyo virus disease .

Clinical Trials and Vaccine Development

Multiple candidates are being fast-tracked:

• Oxford University — Launched the first human trial of a Bundibugyo vaccine (ChAdOx1 BDBV) in July 2026, evaluating safety and immune response in 50 healthy adults . The Serum Institute of India is the manufacturing partner .
• Moderna — Began a Phase 1 trial of an mRNA-based Bundibugyo vaccine (mRNA-1469) on August 4, 2026, backed by CEPI, with Health Canada clearance . The trial aims to enroll about 80 healthy adults at three sites in Canada .
• WHO — Has convened expert advisory groups that prioritized three treatment candidates for clinical trials: monoclonal antibodies MBP134 and Maftivimab®, and the antiviral remdesivir . The PARTNERS platform trial began enrolling patients in DRC on July 2, 2026, to evaluate these treatments . WHO anticipates 7–9 months before an rVSV-based Bundibugyo vaccine could reach clinical use .
• CEPI has committed up to $50 million to fast-track three vaccine candidates, including those from Oxford/Serum Institute, Moderna, and IAVI (International AIDS Vaccine Initiative) .

U.S. Funding Commitment

On August 5, 2026, the U.S. State Department announced it intends to provide an additional $242 million for immediate Ebola response, preparedness, and humanitarian assistance in the region . This brings total direct U.S. Ebola support to more than $512 million . The U.S. has been the largest financial contributor to the Ebola response since the outbreak began .

Outbreak Likely Began Months Earlier

The outbreak was officially declared on May 15, 2026, when 8 lab-confirmed cases and 246 suspected cases were already identified . Epidemiological evidence strongly suggests the virus had been circulating undetected since late 2025 or early 2026, meaning it was spreading for months before the official declaration . This delayed detection allowed the outbreak to become deeply entrenched across multiple provinces before a coordinated response could begin.